Some drugs being tested as Covid-19 treatments could be very cheap to make
Some of the medicines that researchers are studying as potential #coronavirus treatments could be manufactured profitably for as little as $1 to $29 per course of treatment, according to a…
Some existing medicines that may be repurposed to fight Covid-19 could also be manufactured profitably for as little as $1 to $29 per course of treatment, a move that could dramatically widen availability across the globe, according to a new study.
For instance, the researchers calculated that remdesivir, the experimental Gilead Sciences () drug originally tested for Ebola, could be made for just 93 cents for a day’s supply. And a Roche () drug called Esbriet, which is used to treat idiopathic pulmonary fibrosis, could be made for $1.09 for a day’s supply, in the Journal of Virus Eradication.
